Adherium, Summatix enter partnership

06:52 EDT 22 Aug 2019 | SmartBrief

Adherium and Summatix entered a data-based partnership that aims to improve chronic obstructive pulmonary disease and asthma  -More

Original Article: Adherium, Summatix enter partnership


More From BioPortfolio on "Adherium, Summatix enter partnership"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...